Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12006306 Substituted pyridazines as TYK2 inhibitors

Patent 12006306 was granted and assigned to Alumis on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Alumis

Current Assignee

Alumis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120063060

Patent Inventor Names

Gene Hung0

Bohan Jin0

Qing Dong0

Stephen W. Kaldor0

Date of Patent

June 11, 2024

Patent Application Number

172435080

Date Filed

April 28, 2021

Patent Citations

‌

US Patent 9718822 Macrocyclic compounds as Trk kinase inhibitors

‌

US Patent 9750744 Macrocyclic compounds as Trk kinase inhibitors

‌

US Patent 9840519 Macrocyclic compounds as TRK kinase inhibitors

‌

US Patent 9902741 Macrocyclic compounds as TRK kinase inhibitors

‌

US Patent 10180422 Methods of treating a neuroendocrine tumor

‌

US Patent 10246466 Diaryl macrocycles as modulators of protein kinases

‌

US Patent 10294242 Diaryl macrocycle polymorph

‌

US Patent 10316044 Chiral diaryl macrocycles as modulators of protein kinases

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12006306 Substituted pyridazines as TYK2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API